mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.3 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.3 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
-0.16 |
0.3 |
mRNA |
T0901317 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |